Reported Jun 4, 2014 · Terminated
Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt…
Wockhardt USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Wockhardt Usa Inc. · 20 Waterview Blvd., Suite 3 · Parsippany, NJ · 07054
Is this the product you have?
- Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only
- Manufactured byWockhardt Limited, Mumbai, India
- Distributed byWockhardt USA LLC., 20 Water view Blvd., Parsippany, NJ 07054, USA
- NDC64679-736-02
- Lot codes and dates
- Lot #: LN11423
- Expiry8/15/15
- Amount recalled
- 8712 Bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Wockhardt USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.